Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial

Tero Varimo; Hanna Huopio; Laura Kariola; Sirpa Tenhola; Raimo Voutilainen; Jorma Toppari; Sanna Toiviainen-Salo; Esa Hämäläinen; Mari-Anne Pulkkinen; Mitja Lääperi; Annika Tarkkanen; Kirsi Vaaralahti; Päivi J. Miettinen; Matti Hero; Taneli Raivio

doi:10.1016/S2352-4642(18)30377-8

Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial

Tero Varimo, Hanna Huopio, Laura Kariola, Sirpa Tenhola, Raimo Voutilainen, Jorma Toppari, Sanna Toiviainen-Salo, Esa Hämäläinen, Mari-Anne Pulkkinen, Mitja Lääperi, Annika Tarkkanen, Kirsi Vaaralahti, Päivi J. Miettinen, Matti Hero, Taneli Raivio

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Lancet child & adolescent health
Volym	3
Nummer	2
Sidor (från-till)	109-120
Antal sidor	12
ISSN	2352-4642
DOI	https://doi.org/10.1016/S2352-4642(18)30377-8
Status	Publicerad - feb. 2019
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3123 Kvinno- och barnsjukdomar

Åtkomst av dokument

10.1016/S2352-4642(18)30377-8

Citera det här

Varimo, T., Huopio, H., Kariola, L., Tenhola, S., Voutilainen, R., Toppari, J., Toiviainen-Salo, S., Hämäläinen, E., Pulkkinen, M.-A., Lääperi, M., Tarkkanen, A., Vaaralahti, K., Miettinen, P. J., Hero, M., & Raivio, T. (2019). Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial. Lancet child & adolescent health, 3(2), 109-120. https://doi.org/10.1016/S2352-4642(18)30377-8

@article{a2dfd0f2a63b440f8ff47e1f5a4a0b30,

title = "Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial",

keywords = "CONGENITAL HYPOGONADOTROPIC HYPOGONADISM, ANDROGEN RECEPTOR EXPRESSION, IDIOPATHIC SHORT STATURE, PREDICTED ADULT HEIGHT, AROMATASE INHIBITOR, VERTEBRAL MORPHOLOGY, ADOLESCENT BOYS, HORMONE, DIAGNOSIS, ESTROGEN, 3123 Gynaecology and paediatrics",

author = "Tero Varimo and Hanna Huopio and Laura Kariola and Sirpa Tenhola and Raimo Voutilainen and Jorma Toppari and Sanna Toiviainen-Salo and Esa H{\"a}m{\"a}l{\"a}inen and Mari-Anne Pulkkinen and Mitja L{\"a}{\"a}peri and Annika Tarkkanen and Kirsi Vaaralahti and Miettinen, {P{\"a}ivi J.} and Matti Hero and Taneli Raivio",

year = "2019",

month = feb,

doi = "10.1016/S2352-4642(18)30377-8",

language = "English",

volume = "3",

pages = "109--120",

journal = "Lancet child & adolescent health",

issn = "2352-4642",

publisher = "Elsevier Ltd. ",

number = "2",

}

Varimo, T, Huopio, H, Kariola, L , Tenhola, S, Voutilainen, R, Toppari, J, Toiviainen-Salo, S , Hämäläinen, E , Pulkkinen, M-A, Lääperi, M, Tarkkanen, A, Vaaralahti, K , Miettinen, PJ , Hero, M & Raivio, T 2019, 'Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial', Lancet child & adolescent health, vol. 3, nr. 2, s. 109-120. https://doi.org/10.1016/S2352-4642(18)30377-8

TY - JOUR

T1 - Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty

T2 - a randomised controlled phase 3 trial

AU - Varimo, Tero

AU - Huopio, Hanna

AU - Kariola, Laura

AU - Tenhola, Sirpa

AU - Voutilainen, Raimo

AU - Toppari, Jorma

AU - Toiviainen-Salo, Sanna

AU - Hämäläinen, Esa

AU - Pulkkinen, Mari-Anne

AU - Lääperi, Mitja

AU - Tarkkanen, Annika

AU - Vaaralahti, Kirsi

AU - Miettinen, Päivi J.

AU - Hero, Matti

AU - Raivio, Taneli

PY - 2019/2

Y1 - 2019/2

KW - CONGENITAL HYPOGONADOTROPIC HYPOGONADISM

KW - ANDROGEN RECEPTOR EXPRESSION

KW - IDIOPATHIC SHORT STATURE

KW - PREDICTED ADULT HEIGHT

KW - AROMATASE INHIBITOR

KW - VERTEBRAL MORPHOLOGY

KW - ADOLESCENT BOYS

KW - HORMONE

KW - DIAGNOSIS

KW - ESTROGEN

KW - 3123 Gynaecology and paediatrics

U2 - 10.1016/S2352-4642(18)30377-8

DO - 10.1016/S2352-4642(18)30377-8

M3 - Article

SN - 2352-4642

VL - 3

SP - 109

EP - 120

JO - Lancet child & adolescent health

JF - Lancet child & adolescent health

IS - 2

ER -